Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

TERMIS 2021 | Ensuring successful commercialization of advanced therapies

Kurt Gielen, MedAce, Maastricht, The Netherlands, comments on important factors researchers and academics must consider when attempting to commercialize their product for clinical use. He highlights the need to focus on developing the final product, as opposed to constantly making changes. The financial aspects of developing the product must also be considered, as long term costs such as manufacturing costs will overshadow the viability of the product regardless of scientific innovations. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).